Refine by
Galapagos Psoriasis Equipment & Supplies
2 equipment items found
Manufactured by:Galapagos NV based inMechelen, BELGIUM
A TYK2 inhibitor for which topline results from the Phase 1b in psoriasis were reported in July 2021. Phase 2 studies in dermatomyositis and Systemic Lupus Erythematosus (SLE) are expected to start in ...
Manufactured by:Galapagos NV based inMechelen, BELGIUM
In the course of 2013, GSK initiated Phase 2 studies with GSK2586184 (formerly GLPG0778) in systemic lupus erythematosus, chronic plaque psoriasis, and ulcerative colitis. In February 2014, GSK stopped the lupus study due to a lack of effect and put the ulcerative colitis study on hold. In April ...